top of page
Logomark-01.png
Asset 20_4x-20.jpg

Newly incorporated. Anything but a start up in experience.

Asset 5_4x_edited.png

A precision-engineered L-605 cobalt-chrome coronary stent platform combined with

controlled sirolimus delivery and the proprietary SilkTech (TM) hydrophilic delivery

system.

Precision engineering.
Controlled drug delivery.

sirolimus drug-eluting stent system

Steadiflex DES

PLATFORM

L-605
Cobalt- Chrome

STRUT THICKNESS

73 µm

DELIVERY

SilkTech (TM)
Hydrophilic

LOADING DOSE

1.4 µg / mm2m2

Asymmetric coating

Targeted drug distribution

Steadiflex DES uses an asymmetric coating architecture designed to concentrate a greater proportion of the sirolimus-containing coating on the abluminal surface facing the vessel wall, with a thinner coating layer on the luminal surface facing the bloodstream.

Asset 2_4x.png

SILKTECH™ delivery & drug science 

Engineered for the Vessel

PUSHABILITY

Confident force transmission through complex, calcified lesions

TRACKABILITY

Smooth navigation in tortuous, angulated anatomy

torque control

Responsive, predictable handling with precise placement

SILKTECH™ Hydrophilic
System

A proprietary hydrophilic coating dramatically reduces friction through tortuous coronary anatomy - for confident, predictable stent placement.

115-120 Days

Full Polymer Diodegration

99% Drug Released

40-42 Days

Implantation

Day 0

01

Inhibition of the mTOR pathway

03

Reduction of neointimal hyperplasia

02

Reduction of smooth-muscle cell proliferation

04

Designed to reduce the risk of in-stent restenosis

controlled drug release

Asset 3_4x.png

Sirolimus / rapamycin

A well-established
antiproliferative mechanism

Therapeutic drug delivery followed by polymer biodegradation

The coating system is designed to provide controlled release of sirolimus following implantation, followed by progressive biodegradation of the polymer carrier. 

Sirolimus acts through inhibition of the mTOR signalling pathway, helping regulate smooth-muscle cell proliferation associated with neointimal growth following coronary intervention.

Asset 4_2x-20.jpg

An established sirolimus mechanism, a fully resorbable polymer system and a precision cobalt-chrome platform - engineered for controlled therapy and durable vessel support.

Asset 5_4x.png

sizing & compliance

Comprehensive coronary coverage

Steadiflex DES is available across a broad range of diameters and lengths designed to address diverse coronary anatomies. Compliance data should be published only after final verification against the approved IFU.

Asset 4_4x.png

*Technical specifications and compliance data must be verified against the final approved IFU before publication.

bottom of page